<html>
<head>
<title>D075.M.200.B.25</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>STUDYS IN UNITED STATES, PHILADELPHIA, AND JEFFERSON MEDICAL COLLEGE</a>
<a name="2">[2]</a> <a href="#2" id=2>A series of studys happened in United States, Philadelphia, Jefferson Medical College, and other places between Apr. 28, 1988 and Apr. 18, 1991.</a>
<a name="3">[3]</a> <a href="#3" id=3>Studys from 1983, 1986 and 1987 are also mentioned.</a>
<a name="4">[4]</a> <a href="#4" id=4>In a study at the Jefferson Medical College in Philadelphia, a group of laboratory rats induced to have heart attacks suffered 50 percent less cell damage after injections of transforming growth factor beta than did rats that did not receive the TGF beta.</a>
<a name="5">[5]</a> <a href="#5" id=5>The study was conducted in Minneapolis, Los Angeles, Philadelphia and Little Rock, Ark., and published in on Oct. 3, 1990's New England Journal of Medicine.</a>
<a name="6">[6]</a> <a href="#6" id=6>In the study, conducted at 20 community hospitals, doctors compared 897 patients who got Verapamil after heart attacks with 878 people who took placebos.</a>
<a name="7">[7]</a> <a href="#7" id=7>A drug used to treat patients complaining of chest pain could help prevent recurring heart attacks in four out of five heart patients, according to a study published in on Aug. 18, 1988's edition of the New England Journal of Medicine.</a>
<a name="8">[8]</a> <a href="#8" id=8>Surprisingly, however, the study found that the drug, diltiazem, increases the chance of a subsequent heart attack in patients whose hearts pump abnormally, experts said.</a>
</body>
</html>
